Gainers
Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday.
GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 100.6% to $6.54 in pre-market trading after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership.
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) rose 74.1% to $0.18 in pre-market trading after dipping around 34% on Wednesday.
Exicure, Inc. (NASDAQ: XCUR) shares rose 73.4% to $3.45 in pre-market trading after climbing around 27% on Wednesday.
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares rose 73% to $0.1955 in pre-market trading after gaining around 9% on Wednesday.
Greenpro Capital Corp. (NASDAQ: GRNQ) rose 38.8% to $2.43 in pre-market trading after climbing around 14% on Tuesday after climbing 28% on Wednesday.
Yellow Corporation (NASDAQ: YELL) rose 32.9% to $6.26 in pre-market trading after the company swung to a profit for the second quarter.
American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) shares rose 31.4% to $0.23 in pre-market trading.
Embark Technology, Inc. (NASDAQ: EMBK) rose 28.7% to $0.6641 in pre-market trading.
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares rose 24.2% to $5.49 in pre-market trading after gaining over 12% on Wednesday.
Legacy Housing Corporation (NASDAQ: LEGH) rose 24.1% to $16.76 in pre-market trading. Legacy Housing will restate its 1st, 2nd, 3rd quarters unaudited interim financial statements for FY21, Reuters reported.
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) rose 22.8% to $1.08 in pre-market trading. Syros receives positive opinion on orphan drug designation from the European Medicines Agency for Tamibarotene for the treatment of MDS.
Global Blood Therapeutics, Inc. (NASDAQ: GBT) rose 19.3% to $40.47 in pre-market trading following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal.
RedHill Biopharma Ltd. (NASDAQ: RDHL) rose 16.2% to $1.13 in pre-market trading after gaining ...
Benzinga
